Surprise Marijuana Policy Shake-Up

Person in red hoodie blowing smoke rings.

President Trump’s latest executive order accelerates the reclassification of marijuana to a lower-risk category, sparking debate about federal drug policies.

Story Highlights

President Trump signs an executive order to expedite marijuana’s rescheduling to Schedule III.
No credible reports confirm fentanyl as a Weapon of Mass Destruction (WMD).
Marijuana reclassification may relieve industry from onerous tax burdens.

Trump’s Executive Order on Marijuana

On December 18, 2025, President Donald Trump signed an executive order mandating the Attorney General to expedite marijuana’s rescheduling from Schedule I to Schedule III under the Controlled Substances Act. This move aims to enhance access to medical cannabis and alleviate tax burdens on the industry by eliminating the §280E tax code restrictions, which previously disallowed business deductions for cannabis companies.

The reclassification process began during the Biden administration, with HHS recommending the change in August 2023 based on evidence of marijuana’s medical benefits. The DEA had proposed a rule change in May 2024 but faced delays. Trump’s intervention is poised to accelerate the process, much to the relief of industry stakeholders.

Fentanyl WMD Declaration: A Misleading Claim

Despite circulating rumors, there have been no official declarations categorizing fentanyl as a Weapon of Mass Destruction. The opioid crisis remains a separate issue, with fentanyl classified as a Schedule II substance. This misinformation may have arisen from conflated discussions on opioid policies and national security, but it lacks any legislative or executive backing.

Fentanyl’s classification continues to be a point of contention, but without any new law, it remains under its current scheduling. This clarification is crucial to prevent further dissemination of false narratives that could distract from genuine policy discussions.

Impact on the Cannabis Industry

The reclassification of marijuana to Schedule III is expected to bring significant economic benefits to the cannabis industry. By removing the §280E tax restrictions, businesses can anticipate a 30-70% increase in profits due to allowable deductions. This move also opens up banking opportunities for state-legal operators, enhancing financial stability and growth potential.

While the industry stands to gain economically, the federal illegality of marijuana remains a barrier to full reform. Nonetheless, the executive order represents a decisive step toward aligning federal policies with state-level legalizations, providing a clearer path for future legislative actions.